Brief: Asahi Kasei, Axolabs Partners To Accelerate Oligonucleotide Therapeutics Development
April 11 (Reuters) - Asahi Kasei Bioprocess and Axolabs:
* ASAHI KASEI BIOPROCESS AND AXOLABS ANNOUNCE STRATEGIC
PARTNERSHIP TO ACCELERATE OLIGONUCLEOTIDE THERAPEUTICS
DEVELOPMENT
Source text for Eikon: ID:nBw5WrCdca
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ASAHI KASEI
See all newsBrief: Asahi Kasei Corporation - Subsidiary To Launch Tender Offer For Shares Of Mori-Gumi
Table: ASAHI KASEI -6-MTH group results
Brief: Asahi Kasei Corporation - Announces Cancellation Of Treasury Shares
US FDA approves Asahi Kasei's drug for persistent herpes infections
Table: Asahi Kasei -Q1 group results